CONFINE: Birth Experience During COVID-19 Confinement

Sponsor
Central Hospital, Nancy, France (Other)
Overall Status
Recruiting
CT.gov ID
NCT04348929
Collaborator
(none)
927
1
3
41.5
22.3

Study Details

Study Description

Brief Summary

Different studies have demonstrated that the absence of companionship during labor and childbirth may be responsible for a negative birth experience, an increased risk of postnatal depression and/or post traumatic stress disorders. These situation may also have a negative impact on mother-child interaction, on marital and family relationship and on the rate of maternal suicide in postpartum. However, these previous results cannot be extrapolated in the current context where the absence of the companionship is imposed by the confinement framework. The objective of the CONFINE study is to assess, for the first time, the birth experience of women in the context of limited social support in the immediate post-partum period due to confinement, as well as the associated over-risk of mental disorders, compared to a post-partum without social restriction.

Condition or Disease Intervention/Treatment Phase
  • Other: Self-administered questionnaires
N/A

Detailed Description

The primary objective is to compare, in immediate post-partum, the maternal sense of control during childbirth between a group of women who gave birth during confinement ("confinement" group) versus a group of women who gave birth after confinement but in the context of epidemic ("epidemic" group) versus a group of control women ("control" group; excluding confinement and context of epidemic).

The secondary objectives are:
  1. To compare, at two months post-partum, the maternal sense of control during childbirth between the three groups.

  2. To compare, at two months of post-partum, scoring of self-questionnaire Edinburg Postnatale Depression Scale (EPDS) for the post-natal depression between the three groups.

  3. To compare at two months of post-partum, scoring of self-questionnaire Impact of Event Scale - Revised (IES-R) for posttraumatic stress disorder, between the three groups.

  4. To compare, at two months of post-partum, the breastfeeding between the three groups.

  5. To compare, at two months of post-partum, the quality of life (SF-12) between the three groups.

  6. To compare the evolution of quality of life at two months of post-partum between the three groups.

  7. To compare the rate of post-natal depression between the three groups.

Study Design

Study Type:
Interventional
Anticipated Enrollment :
927 participants
Allocation:
Non-Randomized
Intervention Model:
Parallel Assignment
Masking:
None (Open Label)
Primary Purpose:
Screening
Official Title:
Birth Experience During COVID-19 Confinement (Confinement and Fostering Intrapartum Care)
Actual Study Start Date :
Apr 16, 2020
Anticipated Primary Completion Date :
Aug 16, 2023
Anticipated Study Completion Date :
Oct 1, 2023

Arms and Interventions

Arm Intervention/Treatment
Experimental: Confinement group

Delivery during covid-19 confinement period

Other: Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)

Other: Control group

Delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

Other: Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)

Other: Epidemic group

Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)

Other: Self-administered questionnaires
Self-administered questionnaires once during the post-natal hospitalization and a second time 7 to 9 weeks after the delivery (at home)

Outcome Measures

Primary Outcome Measures

  1. "Labor Agentry Scale questionnaire" score in immediate post-partum (duration of hospital stay) [through study completion, an average of 16 months]

Secondary Outcome Measures

  1. "Labor Agentry Scale questionnaire" score at two months after birth [through study completion, an average of 16 months]

  2. Edinburg Postnatale Depression Scale questionnaire" score at two months after birth [through study completion, an average of 16 months]

    To detect suspicion of Post-Partum Depression

  3. "Impact of Event Scale - Revised questionnaire" score at two months after birth [through study completion, an average of 16 months]

    To detect suspicion of Post traumatic stress syndrome

  4. Breastfeeding statement at two months after birth [through study completion, an average of 16 months]

  5. "SF-12 Quality of life questionnaire" score at two months after birth [through study completion, an average of 16 months]

  6. "SF-12 Quality of life questionnaire" score in immediate post-partum [through study completion, an average of 16 months]

  7. Diagnosis of post-natal depression (made by a specialist) [through study completion, an average of 16 months]

Eligibility Criteria

Criteria

Ages Eligible for Study:
18 Years and Older
Sexes Eligible for Study:
Female
Accepts Healthy Volunteers:
No
Inclusion Criteria:
  • Woman who is >= 18 years old

  • Woman having just given birth from 37 weeks of gestation (singleton pregnancy)

  • Woman affiliated to a social security

  • Woman with a level of understanding of written French sufficient to answer the questionnaires.

  • Woman having received complete information on the organization of the research and having given her informed consent in written form.

Specific inclusion criteria according to the group For "confinement"group : Delivery during covid-19 confinement period

For "epidemic" group: Delivery after confinement period and before the withdrawal of sanitary measures implemented (mask, social distancing, limited visits during post-partum immediate)

For "control" group: Start of pregnancy after confinement and delivery after the withdrawal of all sanitary measures (mask, social distancing, limited visits during post-partum immediate)

Exclusion Criteria:
  • Major mentioned in articles L.1121-6 and L-1121-8 of Health Public Code.

  • Woman with psychiatric disorders such as depressive syndrome

  • Woman considered positive for covid-19 and treated as such at the time of delivery (regardless of test result)

  • Newborn with congenital abnormalities

  • Stillbirth

Contacts and Locations

Locations

Site City State Country Postal Code
1 Centre Hospitalier RĂ©gional Universitaire de Nancy Nancy France 54000

Sponsors and Collaborators

  • Central Hospital, Nancy, France

Investigators

  • Study Chair: Charline BERTHOLDT, Centre Hospitalier RĂ©gional Universitaire de Nancy

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.
Responsible Party:
BERTHOLDT Charline, Principal Investigator (obstetrician-gynecologist), Central Hospital, Nancy, France
ClinicalTrials.gov Identifier:
NCT04348929
Other Study ID Numbers:
  • 2020-A00881-38
First Posted:
Apr 16, 2020
Last Update Posted:
Sep 5, 2021
Last Verified:
Aug 1, 2021
Individual Participant Data (IPD) Sharing Statement:
Yes
Plan to Share IPD:
Yes
Studies a U.S. FDA-regulated Drug Product:
No
Studies a U.S. FDA-regulated Device Product:
No
Keywords provided by BERTHOLDT Charline, Principal Investigator (obstetrician-gynecologist), Central Hospital, Nancy, France
Additional relevant MeSH terms:

Study Results

No Results Posted as of Sep 5, 2021